BOHEMIA, NY / March 8, 2024 / Scientific Industries, Inc. ("SI") (OTCQB:SCND) announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc. ("SBI"), effective March 4, 2024. Mr....
Delcath Systems to Participate in Upcoming Investor Conferences
NEW YORK, March 8, 2024 -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that Company management will be attending the following upcoming investor...
Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye
Encinitas, California--(March 8, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced the publication of results from a Phase 1 double-masked study of KIO-101, a potent, non-steroidal anti-inflammatory agent. KIO-101 contains the...
InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Reviva to Present at the 36th Annual ROTH Conference
CUPERTINO, Calif., March 07, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
Webcast presentation to take place at 11:25am ETROCKVILLE, Md., March 05, 2024 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated...
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
CARMEL, Ind., March 04, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced receipt...
Registration Is Now Open for Tribe Public’s Webinar Event “Revolutionizing Diabetes Care” Featuring Modular Medical CEO on Wednesday, March 6, 2024
Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin injection. Only 20% currently use an insulin pump.Discover how...
Reliq Health Technologies, Inc. Announces Expansion of Mental Health Services
HAMILTON, Ontario, Feb. 27, 2024 -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) ("Reliq" or the "Company"), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare...
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
PORTLAND, Maine, Feb. 27, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...